Methotrexate
- Product NDC
- 70518-3263
- 11-digit product format
- 705183263
- Labeler code
- 70518
- Product ID
- 70518-3263_eb79acfb-d703-ba5a-e053-2995a90a04af
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methotrexate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA213343
- Marketing category
- ANDA
- Marketing start
- 2021-11-02
- Marketing end
- 0000-00-00
- Substance
- METHOTREXATE SODIUM
- Active strength
- 3 mg/1
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3263-0 | 70518326300 | 30 TABLET in 1 BLISTER PACK (70518-3263-0) | 30 tablet | 2021-11-02 | 0000-00-00 | No | No | Current |
| 70518-3263-1 | 70518326301 | 100 POUCH in 1 BOX (70518-3263-1) > 1 TABLET in 1 POUCH (70518-3263-2) | 100 pouch | 2022-02-15 | 0000-00-00 | No | No | Current |
| 70518-3263-3 | 70518326303 | 12 TABLET in 1 BOTTLE, PLASTIC (70518-3263-3) | 12 tablet | 2022-09-11 | 0000-00-00 | No | No | Current |
| 70518-3263-4 | 70518326304 | 20 TABLET in 1 BOTTLE, PLASTIC (70518-3263-4) | 20 tablet | 2022-10-19 | 0000-00-00 | No | No | Current |